Literature DB >> 1676530

Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil.

H V Curran1, B Birch.   

Abstract

Sixteen healthy volunteers were administered midazolam followed by placebo or the benzodiazepine antagonist, flumazenil, in a double-blind, cross-over study. Flumazenil reversed midazolam-induced sedation on the subjective, psychophysiological and motor indices used. In contrast, there was little evidence of any reversal of amnesic effects, which were assessed using both direct (explicit) and indirect (implicit) measures of memory. Results are discussed in terms of dissociating the sedative and amnesic effects of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676530     DOI: 10.1007/bf02244252

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  The role of midazolam and flumazenil in urology.

Authors:  B R Birch; K Anson; J Gelister; C Parker; R A Miller
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1990

2.  The differential effects of flumazenil on the psychomotor and amnesic actions of midazolam.

Authors:  B Birch; H V Curran
Journal:  J Psychopharmacol       Date:  1990-01       Impact factor: 4.153

3.  Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation.

Authors:  B Ricou; A Forster; A Brückner; P Chastonay; M Gemperle
Journal:  Br J Anaesth       Date:  1986-09       Impact factor: 9.166

4.  The effects of flumazenil, a new benzodiazepine antagonist, on the reversal of midazolam sedation and amnesia in dental patients.

Authors:  N L Rosenbaum; P A Hooper
Journal:  Br Dent J       Date:  1988-12-10       Impact factor: 1.626

5.  RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.

Authors:  A Darragh; R Lambe; M Kenny; I Brick; W Taaffe; C O'Boyle
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

6.  Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.

Authors:  H V Curran; W Schiwy; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Diazepam induces a dissociation between explicit and implicit memory.

Authors:  J M Danion; M A Zimmermann; D Willard-Schroeder; D Grangé; L Singer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Diazepam and memory: evidence for spared memory function.

Authors:  J C Fang; J V Hinrichs; M M Ghoneim
Journal:  Pharmacol Biochem Behav       Date:  1987-11       Impact factor: 3.533

9.  The information that amnesic patients do not forget.

Authors:  P Graf; L R Squire; G Mandler
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1984-01       Impact factor: 3.051

10.  Memory and performance effects of single and 3-week administration of diazepam.

Authors:  M M Ghoneim; S P Mewaldt; J L Berie; J V Hinrichs
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  27 in total

1.  Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity.

Authors:  P Dudchenko; B Paul; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

3.  Agonizing over antagonizing: what do benzodiazepine receptor antagonists demonstrate?

Authors:  M Sarter; G G Berntson; J P Bruno; B S Givens
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

4.  Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys.

Authors:  Leah Makaron; Casey A Moran; Ojas Namjoshi; Sundari Rallapalli; James M Cook; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

5.  Midazolam does not inhibit association formation, just its storage and strengthening.

Authors:  Lynne M Reder; Iain Proctor; John R Anderson; Ferenc Gyulai; Joseph J Quinlan; Joyce M Oates
Journal:  Psychopharmacology (Berl)       Date:  2006-08-03       Impact factor: 4.530

6.  Rapid Tranquilization for Psychiatric Patients with Psychomotor Agitation: What is Known About it?

Authors:  Clayton Gonçalves de Almeida; Mariana Del Grossi Moura; Silvio Barberato-Filho; Fernando de Sá Del Fiol; Rogério Heládio Lopes Motta; Cristiane de Cássia Bergamaschi
Journal:  Psychiatr Q       Date:  2017-12

Review 7.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

8.  Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment.

Authors:  D Hommer; H Weingartner; A Breier
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine.

Authors:  Robert A Veselis; Ruth A Reinsel; Vladimir A Feshchenko; Ray Johnson
Journal:  Anesthesiology       Date:  2004-10       Impact factor: 7.892

10.  GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity.

Authors:  O Blin; D Mestre; O Paut; J L Vercher; C Audebert
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.